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Ab-PET Perioperative MI Perioperative UA Late events
AD (n = 26) 2 8 3
FD In ~ 31) 1 0 4
Normal (n = 20) 2 1 0
Among 26 pts with RD (19 of whom were on anti-anginal therapy at the
time of surgery), only 10 (38%) had perioperative events. The extent of is-
chemia in pts with RD having events (9 ± 7 segments) exceeded that in pts
with RD not having events (6 ± 4 segments, p = NS). In pts with RD, 7/10
pts with events had extensive ischemia (>5 segments), compared with 9/16
without events (p = NS).
Conclusion. Absence of RD by PET confers a low probability of events (es-
pecially UA), comparable to conventional imaging. FD by PET are not associ-
ated with events. However, RD at PET has a low specificity for peri-operative
events (irrespective of extent of RDI; avoidance of events in the absence of
myocardial revascularization may be attributable to medical and anesthetic
measures.
surement of the extent of ischemia, and is highly specific for the diagnosis
of coronary disease.
We investigated the benefit of more accurate identification of ischemia
and a lower frequency of false positives by using PET for risk stratification
in 77 pts (68 ± 9 y, 52 males) undergoing VS (including 39 aortic operations
- 51 %) without recent myocardial revascularization. One or more clinical
risk factors (age> 70, diabetes, angina, prior infarction or heart failure) were
present in 63 pts; 32 had >2 factors. PET followed infusion of 60 mCi of Rb-
82 at rest and after dipyridamole-handgrip stress. Using a quantitative color
scale in a 24 segment model of the left ventricle, scans were reported as nor-
mal, fixed defects only (FD) or reversible (deterioration> 15% with stress)
defects (RD). Events included infarction (MI) and unstable angina (UA), peri-
operatively and at late follow-up (17 ± 6 months) in 74 pts.
Fourteen pts (18%) suffered peri-operative events (5 MI, 9 UA, no cardiac
deaths) giving PET-RD a sensitivity of 71 %. Of 63 pts without events, RD
was present in 16 (p = 0.003) giving a specificity of 66%. Seven pts suffered
late events;
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for a double blind 18-month multi-centre trial comparing picotamide (300
mg t.i.d.), an antiplatelet drug which inhibits thromboxane A2 (TxA2) syn-
thase and antagonizes TxA2 receptor, and placebo. In the study population
as a whole, 151 events (13.1 %) occurred on placebo and 122 (10.6%) on
picotamide, with a relative risk reduction of 19%, (p = 0.056, Logrank test,
intention to treat analysis). The effect of picotamide was assessed in the
A.D.E.P subgroup of diabetic patients, in order to test if the drug was still
effective in patients at higher risk of cardiovascular complications. Diabetic
patients were 438 (230 on picotamide and 208 on placebo). Most of them
were male (80%), with a mean age of 64 years (min 40, max 75). Six per cent
were insulin-dependent. The main risk factors (smoking, hypertension, pre-
vious vascular surgery, anklelarm pressure ratio, WBC count and fibrinogen I
were similarly distributed in the two groups.
Diabetic POAD patients on placebo suffered from a total of 33 cardiovas-
cular events (12 major and 21 minor) (15.9%), whereas those on picotamide
suffered from a total of 20 events (6 major and 14 minor) (8. 7%) (relative re-
duction of risk: 45.2%, p = 0.022 at Logrank test, intention to treat analysis).
Both major and minor events occurred more frequently in the placebo than
in the picotamide group. The overall incidence of major events was 5.8% on
placebo and 2.6% on picotamide (relative risk reduction of 59.8%). Death
occurred in 6 patients on placebo (2.9%) and in 3 on picotamide (1.3%1.
Non fatal major events (stroke, myocardial infarction and amputation) were
6 on placebo and 3 on picotamide. Minor events were 10.1 % on placebo
and 6.1 % on picotamide (relative risk reduction of 39.8%). Adverse reaction,
mainly gastrointestinal, occurred in 16% of patients, regardless of the treat-
ment.
In conclusion, this analysis indicates that Picotamide significantly reduces
cardiovascular events in diabetic POAD patients, suggesting its potential use
in patients at high risk of atherosclerotic progression.
A temporal relation has been established between cocaine ingestion and
acute myocardial infarction. Based on in vitro data, an increase in platelet
aggregation has been hypothesized as a factor contributing to ischemic
events following cocaine abuse. To determine whether cocaine administra-
tion increases platelet aggregation in vivo, 12 healthy volunteers were stud-
ied twice, each subject receiving cocaine (2 mglkg intranasally) or placebo
in a double-blind, randomized, crossover fashion. Aggregation was tested at
baseline and 40, 80 and 120 minutes following administration of the study
drug, using a turbidimetric method. Aggregation was induced using arachi-
donic acid (AA, 625 /lM), epinephrine (5, 10 and 25 /lM), and ADP (1, 2, 4
and 10 /lM). Data are expressed as difference in aggregation (%) [cocaine -
placebo]:
Agonist (/lM) Baseline 40 min 80 min 120 min
ADP 1 o± 1 o± 1 -2 ± 1 -2± 2
2 1 ± 3 o± 2 -4± 2 -5± 3
4 6±5 -2 ± 5 -6± 6 -10± 8
10 4±3 -1± 3 -1± 3 -8± 3
Epinephrine 5 2±9 O± 9 -4± 6 -11 ± 7
10 -6 ± 7 -6± 4 -5± 4 -11 ± 7
25 3±6 -3 ± 4 -5± 6 -13± 6
AA 625 11 ±8 3 ± 12 -3± 11 -2± 14
Data are presented as mean ± SEM. By doubly repeated ANOVA, there
was a decrease in aggregation after cocaine no matter which of these 3
agonists were used (p < 0.05).
Conclusions: These data do not support an increase in platelet aggrega-
tion as a primary cause of myocardial infarction following low dose cocaine
administration. It is unlikely that low dose cocaine causes a direct thrombo-
genic effect. No conclusion can be reached for high dose cocaine.
Effects of Cocaine on Human Platelet
Aggregation In Vivo
Christian M. Heesch, Brian H. Negus, Manfred Steiner, Richard W. Snyder, Donald
D. Mcintire, Paul A. Grayburn, Joy Ashcraft. Jose A. Hernandez, Eric J. Eichhorn.
UTSouthwestern and Dallas VA Medical Centers, Dallas, TX
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Is Persantine Thallium Scintigraphy Cost
Effective and Reliable in the Preoperative
Evaluation of Patients Referred for Peripheral
Vascular Surgery?
Prakash C. Deedwania, Christopher Engelman, Enrique V. Carbajal, Vishnu Bobba,
Gregory Wille. VAMC, Fresno and UCSF School ofMedicine, San Francisco, CA
Asymptomatic CAD has been shown to be associated with a high risk of pe-
rioperative cardiac events in patients (pts) undergoing surgery for peripheral
vascular disease (PVD). Dipyridamole thallium (SPECT) scintigraphy (DTS)
is considered the most useful screening test for stratification of these pts.
Comparative prospective evaluation of various noninvasive tests for detec-
tion of latent CAD in PVD pts is lacking. In this study, 100 consecutive pa-
tients referred for PVD surgery were evaluated by DTS, low work load ex-
ercise treadmill test (En) and ambulatory ECG monitoring (AEM). Pts with
abnormal findings on any of the three noninvasive tests were evaluated with
coronary angiography (angio) for further stratification. Fifty-five pts had re-
versible perfusion defects on DTS. Of the 55 + pts with DTS, 49 had data
on AEM with 39% having evidence of ambulatory ischemia; 48 of the 55 pts
performed Enwith ischemia induced in 13%. Olthe 41 pts with normal DTS
findings, 12 (29%) had ischemia during En (n = 6) or AEM (n = 61; 64% of
these pts had multi-vessel CAD by angio. Statistical modeling and analysis
of important clinical variables, AEM ischemia, and angio findings were com-
pared with DTS for predicting CAD. These analyses revealed that family hx of
CAD, chest pain, smoking, age ~ 65 years, and ischemia on AEM were highly
predictive of CAD with a positive predictive value of 89% and a specificity of
92%. These findings suggest that a careful evaluation of clinical parameters
and AEM results can provide reliable and clinically meaningful data predictive
of significant CAD in pts referred for PVD surgery.
Conclusion: Our data have demonstrated that the findings on DTS are not
always reliable and its routine use might not be warranted in preoperative
evaluation of patients with asymptomatic CAD referred for peripheral vascu-
lar surgery.
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In the A.D.E.P (Atherosclerotic Disease Evolution by Picotamidel study 2,304
patients with peripheral obstructive arterial disease (POAD) were recruited
Francesco Violi 1, Aldo Longoni, Carlo Castiglioni, A.D.E.P. Group. I Clinica Medica
Universita di Rome. Istituto Ricerche LPB Milano, Italy
11013-1091 Effect of Plcotamide in Preventing
Cardiovascular Events in 438 Diabetic Patients:
Results of a Multi-Centre, Placebo Controlled,
18-Month Study
Neil P. Andrews, Michael L. Vail, Donna.Jo Mayo, Harvey R. Gralnick, Arshed
A. Quyyumi. National Institutes of Health, Bethesda, MD
Introduction: Immediately after arising in the morning there is an increase
in the incidence of acute myocardial infarction, stroke and sudden death.
Upon assumption of the upright posture platelet aggregation, as measured
by conventional techniques using platelet rich plasma, occurs more readily
in response to standard aggregating agents. Whether platelet aggregability
in the physiological milieu of whole blood also increases and whether this in-
crease in platelet aggregability is also accompanied by activation-dependent
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Conclusions: Contrary to our hypothesis, orthostatic venous pooling was
not accentuated in diabetics with hyperadrenergic OH+. Their disease is
probably due to end organ resistance to plasma norepinephrine.
output and blood pressure. Based on upright plasma norepinephrine (UPNE).
patients were classified as: hyperadrenergic if UPNE is >55B pglml, hypoad-
renergic if UPNE <495 and normal adrenergic response if 494 >UPNE <558.
Within each group, orthostatic hypotension OH + was defined as a decrease
in systolic blood pressure of >20 mmHg during tilt.
Results:
HyperAdr HypoAdr Norm Adr
OH+ OH- OH+ OH- OH+ OH-
n 12 6 15 10 4 7
t.SBP mmHg -55±25 -12±6' -53±23 -8±8' -62±11 2±24'
t.HR BPM 6±9 7±7 13±18 4±6 13±18 11±8
t.TPR U.M2 0.8±7 12±14 04±7 4±8 4±4 11±8
t.CPVff8V% -2±1 -2.5±3 -1±3 -1±2 -2±1 -2±3
t.PNE Pg/ml 456±512 369±198 49±80t 98±65t 284±33 238±114
x ± SD 'p < 0.0001 YS OH+ (HyperA, HypoA & Norm A). t P < 0.01 YS OH+ (HyperA).
TPR = total peripheral resistance
platelet surface receptor changes is unknown. In addition, further clarifica-
tion of the changes in hemostatic and rheological factors that can promote
platelet aggregation and that may occur upon standing, are required.
Methods and Results: We therefore investigated the effect of arising in the
morning on whole blood impedance aggregometry in 12 normal subjects and
simultaneously measured platelet activation directly by using whole blood
flow cytometry (n = 5). Aggregometry was completed and antibodies were
added within 10 mins of blood withdrawal. Hemodynamic changes (n = 12).
catecholamines (n = 6). fibrinogen (n = 6), platelet count and hematocrit(n =
8) were also measured. Platelet aggregation to ADP and collagen increased
by 75% (p < 0.01) and 32% (p < 0.01) respectively. However, this was not
associated with evidence of activation using flow cytometry. Six markers
(GPlb, P-selectin, activated GPllb-lIla, GPIV, fibrinogen and vWF) tested with
10 antibodies showed no change in either percent positivity or flourescence
intensity. Platelet count and fibrinogen levels increased by 14% (p < 0.01)
and 12% (p < 0.04) respectively which was partly due to hemoconcentra-
tion (hematocrit increased by 7%, p < 0.01). Heart rate and norepinephrine
levels significantly increased by 20% (p < 0.02) and 163% (p < 0.01) respec-
tively.
Conclusions: The observed increase in whole blood platelet aggregation
on arousal and standing in the morning is not accompanied by activation-
dependent platelet surface receptor changes. Thus changes in rheologi-
cal and hemostatic factors, such as increases in platelet count and fibrino-
gen level, together with indirect effects of increases in catecholamine lev-
els may playa more important role in promoting platelet aggregation upon
standing.
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Is the INR an Adequate Corrective Factor for
the Range of Thromboplastins Utilized in North
America?
Alan K. Jacobson, Steven W. Hildebrand, James C. Westengard, Chandra Hart,
Anita McManus, Ramdas G. Pai, David R. Ferry, J. Thomas Heywood. Loma Linda
VAMC & Lama Unda UniversitY- Lama Unda, CA
For a given intensity of anticoagulant therapy the Prothrombin Time Ratio
(PTR) shows wide variability when measured with different thromboplastin
reagents due to differing sensitivities of the commercially available thrombo-
plastins as reflected in differences in the International Sensitivity Index (lSI)
values for each reagent. The International Normalized Ratio (INR) is used to
correct for this variation. We investigated the variability of INR obtained with
11 different thromboplastins from 4 different manufacturers using a single
venipuncture sample from each of 49 unselected patients. The lSI values of
the thromboplastins ranged from 1.0 to 2.81 and all analyses were performed
on a MLA 700 instrument.
Results: For any individual thromboplastin the coefficient of variation (CV)
was verylow-1.6t04.6%. However, when comparing INR values from alill
thromboplastins the CV was 19%, which was a significant improvement over
the CV for PTR of 29%, (p < 0.005) but still high enough to allow for clinically
significant differences as demonstrated by the following confidence ranges:
INR 95% Confidence Range CV
lower limit upper limit
1.6 1.2 20 13%
24 1.7 31 15%
37 20 53 23%
4.7 22 73 27%
The CV and the standard deviation were directly related to the INR with
higher variability at higher levels of anticoagulant intensity.
Conclusion: While the INR offers a significant reduction in variance as com-
pared to the PTR, it is suboptimal for the range of thromboplastins available
in North America, and can result in clinically significant variation when com-
paring INR results between institutions utilizing different thromboplastins,
especially at higher intensities of anticoagulation.
Is Diabetic "Hyperadrenergic Orthostatic
Hypotension" due to End Organ Resistance to
Catecholamines?
Riad R. Hajjar, Abbas Shehadeh, Abdelkarim Waness, Emmanuel L. Bravo, Fetnat
M. Fouad-Tarazi. The Cleveland Clinic Foundation, Cleveland, OH
It has been previously reported that orthostatic hypotension occurs in some
diabetics despite markedly increased standing plasma norepinephrine. The
mechanism for this response remains unclear. We hypothesized that this
"hyperadrenergic response" is triggered by accentuated postural venous
translocation of blood volume (venous pooling). We assessed the hemody-
namic (99m Tc-RBC) and catecholamine responses to upright posture in 54
diabetic patients (30 M: 24 F, age 57.5 ± 13 yrs). Venous translocation was
defined by the ratio of cardiopulmonary volume (CPV) to total blood volume
(TBV, RISA method). Total peripheral resistance was calculated from cardiac
F.H. Shiffman, R.M. Prewitt, U. Schick, J. Ducas. Health Sciences Centre, University
of Manitoba, Winnipeg, Manitoba, Canada
Nitric oxide (NO) has been shown to be effective in reducing pulmonary artery
pressure in many forms of pulmonary hypertension. While the intracellular
mechanism of action is known, the pulmonary hemodynamic effects are not
fully elucidated. This study examined the effects of inhaled NO on the pul-
monary vascular pressure-flow (P-O) relationship in a canine model of pul-
monary embolism. According to P-O theory, the slope of the P-O plot defines
the incremental vascular resistance (unit pressure change per unit change in
flow) and the extrapolated pressure intercept defines the effective vascular
outflow pressure. Six dogs were embolized with autologous blood clot to
create pulmonary hypertension complicated by a low cardiac output state.
To define the P-O plot, multiple mean pulmonary artery pressure (PAP) vs
cardiac output (COl coordinates were obtained pre and post embolization,
and before, during and after treatment with nitric oxide (180-200 ppm). The
PAP-CO coordinates were obtained by varying flow through systemic arteri-
ovenous fistulas. Embolization increased PAP (14.8 ± 1.2 to 34.6 ± 4.6; P <
0.001) and decreased CO (3.45 ± 0.63 to 2.25 ± 0.43; P < 005). All PAP-CO
relationships were well described by a linear equation (mean r value 0.921
± 0.029). Both the slope and intercept of the PAP-CO plot increased with
embolization, (1.41 ± 0.09 to 3.51 ± 1.22; P < 0.05 and 9.9 ± 1.1 to 28.0 ±
6.5; p < 0.005 respectively). NO significantly improved pulmonary hemody-
namics. The intercept of the PAP-CO plot decreased from the initial control
of 28.0 mmHg to 22.5 mmHg (p < 0.05), and following discontinuation of
the NO, increased to 26.2 mmHg (p < 0.05). The slope was not affected.
Furthermore, NO did not affect systemic hemodynamics. In this model of
pulmonary embolism, the increase in PAP is predominantly explained by an
increase in the extrapolated pressure intercept (PI) and NO selectively im-
proved pulmonary hemodynamics by decreasing PI. Conclusion: Based on
previous work, it is most likely that the decrease in PI represents a localized
decrease in pulmonary vascular tone upstream from the capillary bed.
Effect of Pravastatin on Abdominal Aorta and
Carotid Wall Thickness in Dyslipidemia
Giuseppe Gullace, Franco Ruffa. Centro Cardiologia Preventiva e Riabilitativa, USSL;
Lecco. Bosisio Parim: Italy
We studied 85 pts (45 female, 40 male, aged 55 ± 5 yrs) with familiar dys-
lipidemia, to assess the effect of pravastatin 15 mg daily orally administered
on abdominal aorta (M) and carotid (C) wall thickness (WT) compared to
variation of total cholesterol ITCH) and LDL plasma levels. All underwent a 3
months period of dietary fat restriction and included in the study when TCH
was still >240 mg/dl after this period. M-WT and M-WT corrected by the ra-
dius (M-WTIr) were obtained using echography with a 3.5 MHz transducer,
whereas C-WT and intima-media thickness (IMT) were obtained using a 5
MHz one. Media wall thickness (MWT = eWT - IMT) was also considered.
Measurements were detected on basal and after 4.5 ± 1.2 months of ther-
apy. The following results were obtained and compared by means of paired
data t test:
